Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 143

1.

Causes of mortality in older patients with stage 3 colon cancer.

Raycraft T, Cheung WY, Yin Y, Speers C, Ko JJ, Mariano C.

J Geriatr Oncol. 2018 Jun 27. pii: S1879-4068(18)30041-9. doi: 10.1016/j.jgo.2018.06.002. [Epub ahead of print]

PMID:
29960748
2.

Outcomes of Surgical and Chemotherapeutic Treatments of Goblet Cell Carcinoid Tumors of the Appendix.

Tsang ES, McConnell YJ, Schaeffer DF, Lee L, Yin Y, Zerhouni S, Schaff K, Speers C, Kennecke HF.

Ann Surg Oncol. 2018 Aug;25(8):2391-2399. doi: 10.1245/s10434-018-6560-0. Epub 2018 Jun 18.

PMID:
29916007
3.

Circulating Tumors Cells as a Biomarker of Radiation Benefit.

Speers C, Rugo HS.

JAMA Oncol. 2018 Aug 1;4(8):e180194. doi: 10.1001/jamaoncol.2018.0194. Epub 2018 Aug 9. No abstract available.

PMID:
29800965
4.

Factors affecting radiotherapy prescribing patterns in the post-mastectomy setting.

Koulis TA, Dang A, Speers C, Olson RA.

Curr Oncol. 2018 Apr;25(2):e146-e151. doi: 10.3747/co.25.3773. Epub 2018 Apr 30.

5.

Prescribing practices of endocrine therapy for ductal carcinoma in situ in British Columbia.

Chaudhry AT, Koulis TA, Speers C, Olson RA.

Curr Oncol. 2018 Apr;25(2):133-138. doi: 10.3747/co.25.3795. Epub 2018 Apr 30.

6.

Concurrent Veliparib With Chest Wall and Nodal Radiotherapy in Patients With Inflammatory or Locoregionally Recurrent Breast Cancer: The TBCRC 024 Phase I Multicenter Study.

Jagsi R, Griffith KA, Bellon JR, Woodward WA, Horton JK, Ho A, Feng FY, Speers C, Overmoyer B, Sabel M, Schott AF, Pierce L; Translational Breast Cancer Research Consortium.

J Clin Oncol. 2018 May 1;36(13):1317-1322. doi: 10.1200/JCO.2017.77.2665. Epub 2018 Mar 20.

PMID:
29558281
7.

Molecular Signatures of Radiation Response in Breast Cancer: Towards Personalized Decision-Making in Radiation Treatment.

Speers C, Pierce LJ.

Int J Breast Cancer. 2017;2017:4279724. doi: 10.1155/2017/4279724. Epub 2017 Nov 26. Review.

8.

Prognostic Factors for Locoregional Recurrence in Neuroendocrine Tumors of the Rectum.

Tsang ES, McConnell YJ, Schaeffer DF, Yin Y, Speers CH, Kennecke HF.

Dis Colon Rectum. 2018 Feb;61(2):187-192. doi: 10.1097/DCR.0000000000000996.

PMID:
29337773
9.

Defining the Process of a Cardiovascular Risk Assessment Program: Lessons Learnt From Cardiac Assessment of Elite Soccer Players in the United Kingdom.

Speers C, Seth AN, Patel KC, Rakhit DJ, Gillett MJ.

Clin J Sport Med. 2017 Dec 14. doi: 10.1097/JSM.0000000000000534. [Epub ahead of print]

PMID:
29256928
10.

Management of stage II and III rectal cancer in British Columbia: Is there a rural-urban difference?

Lefresne S, Cheung WY, Hay J, Brown CJ, Speers C, Olson R.

Am J Surg. 2017 Dec 6. pii: S0002-9610(17)31332-6. doi: 10.1016/j.amjsurg.2017.11.039. [Epub ahead of print]

PMID:
29254833
11.

Real-World Effect of Maintenance and Intermittent Chemotherapy on Survival in Metastatic Colorectal Cancer.

Loree JM, Tan SK, Lafond LM, Speers CH, Kennecke HF, Cheung WY.

Clin Colorectal Cancer. 2018 Mar;17(1):65-72. doi: 10.1016/j.clcc.2017.10.011. Epub 2017 Oct 23.

PMID:
29153430
12.

Neoadjuvant systemic therapy in breast cancer: use and trends in radiotherapy practice.

Koulis TA, Beecham K, Speers C, Tyldesley S, Voduc D, Simmons C, Olson R.

Curr Oncol. 2017 Oct;24(5):310-317. doi: 10.3747/co.24.3558. Epub 2017 Oct 25.

13.

Greater trochanteric pain syndrome: a review of diagnosis and management in general practice.

Speers CJ, Bhogal GS.

Br J Gen Pract. 2017 Oct;67(663):479-480. doi: 10.3399/bjgp17X693041. No abstract available.

PMID:
28963433
14.

Recent Time Trends and Predictors of Heart Dose From Breast Radiation Therapy in a Large Quality Consortium of Radiation Oncology Practices.

Pierce LJ, Feng M, Griffith KA, Jagsi R, Boike T, Dryden D, Gustafson GS, Benedetti L, Matuszak MM, Nurushev TS, Haywood J, Radawski JD, Speers C, Walker EM, Hayman JA, Moran JM; Michigan Radiation Oncology Quality Consortium.

Int J Radiat Oncol Biol Phys. 2017 Dec 1;99(5):1154-1161. doi: 10.1016/j.ijrobp.2017.07.022. Epub 2017 Jul 22.

PMID:
28927756
15.

Androgen receptor as a mediator and biomarker of radioresistance in triple-negative breast cancer.

Speers C, Zhao SG, Chandler B, Liu M, Wilder-Romans K, Olsen E, Nyati S, Ritter C, Alluri PG, Kothari V, Hayes DF, Lawrence TS, Spratt DE, Wahl DR, Pierce LJ, Feng FY.

NPJ Breast Cancer. 2017 Aug 18;3:29. doi: 10.1038/s41523-017-0038-2. eCollection 2017.

16.

Impact of Duration of Neoadjuvant Radiation on Rectal Cancer Survival: A Real World Multi-center Retrospective Cohort Study.

Abdel-Rahman O, Kumar A, Kennecke HF, Speers CH, Cheung WY.

Clin Colorectal Cancer. 2018 Mar;17(1):e21-e28. doi: 10.1016/j.clcc.2017.06.003. Epub 2017 Jun 23.

PMID:
28709877
17.

Radiogenomics and radiotherapy response modeling.

El Naqa I, Kerns SL, Coates J, Luo Y, Speers C, West CML, Rosenstein BS, Ten Haken RK.

Phys Med Biol. 2017 Aug 1;62(16):R179-R206. doi: 10.1088/1361-6560/aa7c55. Review.

18.

The Use of Hormone Therapy Alone Versus Hormone Therapy and Radiation Therapy for Breast Cancer in Elderly Women: A Population-Based Study.

Nichol AM, Chan EK, Lucas S, Smith SL, Gondara L, Speers C, Tyldesley S.

Int J Radiat Oncol Biol Phys. 2017 Jul 15;98(4):829-839. doi: 10.1016/j.ijrobp.2017.02.094. Epub 2017 Mar 1.

PMID:
28602413
19.

Associations of Luminal and Basal Subtyping of Prostate Cancer With Prognosis and Response to Androgen Deprivation Therapy.

Zhao SG, Chang SL, Erho N, Yu M, Lehrer J, Alshalalfa M, Speers C, Cooperberg MR, Kim W, Ryan CJ, Den RB, Freedland SJ, Posadas E, Sandler H, Klein EA, Black P, Seiler R, Tomlins SA, Chinnaiyan AM, Jenkins RB, Davicioni E, Ross AE, Schaeffer EM, Nguyen PL, Carroll PR, Karnes RJ, Spratt DE, Feng FY.

JAMA Oncol. 2017 Dec 1;3(12):1663-1672. doi: 10.1001/jamaoncol.2017.0751.

20.

The heart of the matter: cardiac assessment in professional footballers.

Speers C, Seth A, Patel K, Gillett M, Rakhit D.

Br J Sports Med. 2017 May 10. pii: bjsports-2017-097827.2. doi: 10.1136/bjsports-2017-097827.2. [Epub ahead of print]

PMID:
28490459
21.

Prize Winning Abstracts from BASEM Congress 2016.

Hughes T, Sergeant JC, Parkes M, Callaghan M, Speers C, Seth A, Patel K, Gillett M, Rakhit D, Radhakrishnan K, Sharma VK, Subramanian SK, Wynter Bee W, Ubhi J, Kumar B, Sahni M, Bhogal G.

Br J Sports Med. 2017 May 9. pii: bjsports-2017-097827. doi: 10.1136/bjsports-2017-097827. [Epub ahead of print] No abstract available.

PMID:
28487441
22.

Pan-Cancer Analysis of Genomic Sequencing Among the Elderly.

Wahl DR, Nguyen PL, Santiago M, Yousefi K, Davicioni E, Shumway DA, Speers C, Mehra R, Feng FY, Osborne JR, Spratt DE.

Int J Radiat Oncol Biol Phys. 2017 Jul 15;98(4):726-732. doi: 10.1016/j.ijrobp.2017.01.002. Epub 2017 Jan 7.

PMID:
28258894
23.

Response to "Do metastasis-free interval less or more than 24 months for recurrent metastatic breast cancer and primary surgery for de novo metastatic breast cancer matter for survival?"

den Brok WD, Speers CH, Gondara L, Baxter E, Tyldesley SK, Lohrisch CA.

Breast Cancer Res Treat. 2017 Apr;162(2):397-398. doi: 10.1007/s10549-017-4114-y. No abstract available.

PMID:
28110478
24.

The utility of abbreviated patient-reported outcomes for predicting survival in early stage colorectal cancer.

Hsu T, Speers CH, Kennecke HF, Cheung WY.

Cancer. 2017 May 15;123(10):1839-1847. doi: 10.1002/cncr.30511. Epub 2017 Jan 12.

25.

Survival with metastatic breast cancer based on initial presentation, de novo versus relapsed.

den Brok WD, Speers CH, Gondara L, Baxter E, Tyldesley SK, Lohrisch CA.

Breast Cancer Res Treat. 2017 Feb;161(3):549-556. doi: 10.1007/s10549-016-4080-9. Epub 2016 Dec 20.

PMID:
28000014
26.

Glioblastoma Therapy Can Be Augmented by Targeting IDH1-Mediated NADPH Biosynthesis.

Wahl DR, Dresser J, Wilder-Romans K, Parsels JD, Zhao SG, Davis M, Zhao L, Kachman M, Wernisch S, Burant CF, Morgan MA, Feng FY, Speers C, Lyssiotis CA, Lawrence TS.

Cancer Res. 2017 Feb 15;77(4):960-970. doi: 10.1158/0008-5472.CAN-16-2008. Epub 2016 Dec 6.

27.

Patterns of practice with third-line anti-EGFR antibody for metastatic colorectal cancer.

Ho MY, Renouf DJ, Cheung WY, Lim HJ, Speers CH, Zhou C, Kennecke HF.

Curr Oncol. 2016 Oct;23(5):329-333. Epub 2016 Oct 25.

28.

Maternal Embryonic Leucine Zipper Kinase (MELK) as a Novel Mediator and Biomarker of Radioresistance in Human Breast Cancer.

Speers C, Zhao SG, Kothari V, Santola A, Liu M, Wilder-Romans K, Evans J, Batra N, Bartelink H, Hayes DF, Lawrence TS, Brown PH, Pierce LJ, Feng FY.

Clin Cancer Res. 2016 Dec 1;22(23):5864-5875. Epub 2016 May 25.

29.

Development and validation of a 24-gene predictor of response to postoperative radiotherapy in prostate cancer: a matched, retrospective analysis.

Zhao SG, Chang SL, Spratt DE, Erho N, Yu M, Ashab HA, Alshalalfa M, Speers C, Tomlins SA, Davicioni E, Dicker AP, Carroll PR, Cooperberg MR, Freedland SJ, Karnes RJ, Ross AE, Schaeffer EM, Den RB, Nguyen PL, Feng FY.

Lancet Oncol. 2016 Nov;17(11):1612-1620. doi: 10.1016/S1470-2045(16)30491-0. Epub 2016 Oct 12.

PMID:
27743920
30.

Impact of Travel Distance and Urban-Rural Status on the Multidisciplinary Management of Rectal Cancer.

Loree JM, Javaheri KR, Lefresne SV, Speers CH, Ruan JY, Chang JT, Brown CJ, Kennecke HF, Olson RA, Cheung WY.

J Rural Health. 2017 Sep;33(4):393-401. doi: 10.1111/jrh.12219. Epub 2016 Oct 7.

PMID:
27717002
31.

Population-Based Patterns and Factors Associated With Underuse of Palliative Systemic Therapy in Elderly Patients With Metastatic Colon Cancer.

Chan M, Hugh-Yeun K, Gresham G, Speers CH, Kennecke HF, Cheung WY.

Clin Colorectal Cancer. 2017 Jun;16(2):147-153. doi: 10.1016/j.clcc.2016.08.004. Epub 2016 Aug 30.

PMID:
27670894
32.

The lncRNA landscape of breast cancer reveals a role for DSCAM-AS1 in breast cancer progression.

Niknafs YS, Han S, Ma T, Speers C, Zhang C, Wilder-Romans K, Iyer MK, Pitchiaya S, Malik R, Hosono Y, Prensner JR, Poliakov A, Singhal U, Xiao L, Kregel S, Siebenaler RF, Zhao SG, Uhl M, Gawronski A, Hayes DF, Pierce LJ, Cao X, Collins C, Backofen R, Sahinalp CS, Rae JM, Chinnaiyan AM, Feng FY.

Nat Commun. 2016 Sep 26;7:12791. doi: 10.1038/ncomms12791.

33.

A Comparison of Survival by Site of Metastatic Resection in Metastatic Colorectal Cancer.

Lee-Ying R, Bernard B, Gresham G, Chen L, Speers C, Kennecke HF, Lim HJ, Cheung WY, Renouf DJ.

Clin Colorectal Cancer. 2017 Jun;16(2):e23-e28. doi: 10.1016/j.clcc.2016.07.018. Epub 2016 Aug 9.

PMID:
27637559
34.

Racial/Ethnic Disparities in Genomic Sequencing.

Spratt DE, Chan T, Waldron L, Speers C, Feng FY, Ogunwobi OO, Osborne JR.

JAMA Oncol. 2016 Aug 1;2(8):1070-4. doi: 10.1001/jamaoncol.2016.1854.

35.

Effect of Adjuvant Chemotherapy on Stage II Rectal Cancer Outcomes After Preoperative Short-Course Radiotherapy.

Loree JM, Kennecke HF, Renouf DJ, Lim HJ, Vickers MM, Speers CH, Cheung WY.

Clin Colorectal Cancer. 2016 Dec;15(4):352-359.e1. doi: 10.1016/j.clcc.2016.04.003. Epub 2016 May 7.

PMID:
27265355
36.

Postoperative Radiotherapy After Breast-Conserving Surgery for Early-Stage Breast Cancer: A Review.

Speers C, Pierce LJ.

JAMA Oncol. 2016 Aug 1;2(8):1075-82. doi: 10.1001/jamaoncol.2015.5805. Review.

PMID:
27243924
37.

Risk of Recurrence or Contralateral Breast Cancer More than 5 Years After Diagnosis of Hormone Receptor-Positive Early-Stage Breast Cancer.

Wilson S, Speers C, Tyldesley S, Chia S, Kennecke H, Ellard S, Lohrisch C.

Clin Breast Cancer. 2016 Aug;16(4):284-90. doi: 10.1016/j.clbc.2015.11.002. Epub 2015 Nov 17.

PMID:
26705158
38.

Reasons for Underuse of Adjuvant Chemotherapy in Elderly Patients With Stage III Colon Cancer.

Ko JJ, Kennecke HF, Lim HJ, Renouf DJ, Gill S, Woods R, Speers C, Cheung WY.

Clin Colorectal Cancer. 2016 Jun;15(2):179-85. doi: 10.1016/j.clcc.2015.09.002. Epub 2015 Sep 30.

PMID:
26520019
39.

Simplified 2-tier histologic grading system accurately predicts outcomes in goblet cell carcinoid of the appendix.

Lee LH, McConnell YJ, Tsang E, Zerhouni S, Speers C, Kennecke H, Schaeffer DF.

Hum Pathol. 2015 Dec;46(12):1881-9. doi: 10.1016/j.humpath.2015.08.005. Epub 2015 Aug 22.

PMID:
26433702
40.

Effect of Adjuvant FOLFOX Chemotherapy Duration on Outcomes of Patients With Stage III Colon Cancer.

Kumar A, Peixoto RD, Kennecke HF, Renouf DJ, Lim HJ, Gill S, Speers CH, Cheung WY.

Clin Colorectal Cancer. 2015 Dec;14(4):262-8.e1. doi: 10.1016/j.clcc.2015.05.010. Epub 2015 Jun 6.

PMID:
26123496
41.

Population-based analysis of the impact and generalizability of the NSABP-B24 study on endocrine therapy for patients with ductal carcinoma in situ of the breast.

Lo AC, Truong PT, Wai ES, Nichol A, Weir L, Speers C, Hayes MM, Baliski C, Tyldesley S.

Ann Oncol. 2015 Sep;26(9):1898-903. doi: 10.1093/annonc/mdv251. Epub 2015 Jun 10.

PMID:
26063632
42.

High-throughput transcriptomic analysis nominates proteasomal genes as age-specific biomarkers and therapeutic targets in prostate cancer.

Zhao SG, Jackson WC, Kothari V, Schipper MJ, Erho N, Evans JR, Speers C, Hamstra DA, Niknafs YS, Nguyen PL, Schaeffer EM, Ross AE, Den RB, Klein EA, Jenkins RB, Davicioni E, Feng FY.

Prostate Cancer Prostatic Dis. 2015 Sep;18(3):229-36. doi: 10.1038/pcan.2015.22. Epub 2015 May 19.

43.

Development and validation of a novel platform-independent metastasis signature in human breast cancer.

Zhao SG, Shilkrut M, Speers C, Liu M, Wilder-Romans K, Lawrence TS, Pierce LJ, Feng FY.

PLoS One. 2015 May 14;10(5):e0126631. doi: 10.1371/journal.pone.0126631. eCollection 2015.

44.

Development and Validation of a Novel Radiosensitivity Signature in Human Breast Cancer.

Speers C, Zhao S, Liu M, Bartelink H, Pierce LJ, Feng FY.

Clin Cancer Res. 2015 Aug 15;21(16):3667-77. doi: 10.1158/1078-0432.CCR-14-2898. Epub 2015 Apr 22.

45.

Prognostic factors and sites of metastasis in unresectable locally advanced pancreatic cancer.

Peixoto RD, Speers C, McGahan CE, Renouf DJ, Schaeffer DF, Kennecke HF.

Cancer Med. 2015 Aug;4(8):1171-7. doi: 10.1002/cam4.459. Epub 2015 Apr 18.

46.

Time to adjuvant chemotherapy and survival outcomes among patients with stage 2 to 3 rectal cancer treated with preoperative chemoradiation.

Gresham G, Cheung WY, Speers C, Woods R, Kennecke H.

Clin Colorectal Cancer. 2015 Mar;14(1):41-5. doi: 10.1016/j.clcc.2014.11.004. Epub 2014 Nov 20.

PMID:
25548075
47.

Effect of delay in adjuvant oxaliplatin-based chemotherapy for stage III colon cancer.

Peixoto RD, Kumar A, Speers C, Renouf D, Kennecke HF, Lim HJ, Cheung WY, Melosky B, Gill S.

Clin Colorectal Cancer. 2015 Mar;14(1):25-30. doi: 10.1016/j.clcc.2014.10.002. Epub 2014 Nov 4.

PMID:
25465343
48.

Comparison of breast cancer recurrence and outcome patterns between patients treated from 1986 to 1992 and from 2004 to 2008.

Cossetti RJ, Tyldesley SK, Speers CH, Zheng Y, Gelmon KA.

J Clin Oncol. 2015 Jan 1;33(1):65-73. doi: 10.1200/JCO.2014.57.2461. Epub 2014 Nov 24.

PMID:
25422485
49.

A comprehensive assessment of the prognostic utility of the Stephenson nomogram for salvage radiation therapy postprostatectomy.

Johnson S, Jackson W, Speers C, Feng F, Hamstra D.

Pract Radiat Oncol. 2014 Nov-Dec;4(6):422-9. doi: 10.1016/j.prro.2014.02.003. Epub 2014 Mar 27.

PMID:
25407865
50.

Adjuvant chemotherapy use and outcomes of patients with high-risk versus low-risk stage II colon cancer.

Kumar A, Kennecke HF, Renouf DJ, Lim HJ, Gill S, Woods R, Speers C, Cheung WY.

Cancer. 2015 Feb 15;121(4):527-34. doi: 10.1002/cncr.29072. Epub 2014 Oct 20.

Supplemental Content

Loading ...
Support Center